Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option? [Gastrointestinal Cancer]

Conclusion The results of this large multicenter study from the modern era suggest that SALV can offer acceptable short- and long-term outcomes in selected patients at experienced centers. Persistent cancer after definitive chemoradiotherapy seems to be more biologically aggressive, with poorer survival compared with recurrent cancer.

http://jco.ascopubs.org/cgi/content/short/33/33/3866?rss=1

Source: Journal of Clinical Oncology - November 18, 2015 Category: Cancer & Oncology Authors: Markar, Gronnier, Duhamel, Pasquer, Thereaux, du Rieu, Lefevre, Turner, Luc, Mariette Tags: Surgery, Combined Modality Gastrointestinal Cancer Source Type: research